Catalent redeems $304.1 million notes after $45.9 million tendered

New York, Nov. 13 - Catalent Pharma Solutions, Inc. said it redeemed $304.1 million of its 9½%/10¼% senior PIK-election notes due 2015 on Nov. 1.

The company paid $311.4 million plus accrued interest, according to a 10-Q filing with the Securities and Exchange Commission.

Catalent had previously purchased $45.9 million of the toggle notes in a tender offer that settled on Sept. 18.

In the tender offer, the company had been offering to buy up to $350 million of the $619,133,490 of notes outstanding. The tender cap was increased from $250 million.

Catalent is a Somerset, N.J.-based provider of technologies and services for pharmaceutical, biotechnology and health-care companies.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.